Citadel Advisors’s Ensysce Biosciences ENSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,574
| Closed | -$5.67K | – | 6178 |
|
|
2024
Q3 | $5.67K | Sell |
1,574
-4,182
| -73% | -$15.1K | ﹤0.01% | 5500 |
|
|
2024
Q2 | $43.7K | Buy |
+5,756
| New | +$43.7K | ﹤0.01% | 5220 |
|
|
2023
Q4 | – | Sell |
-1,274
| Closed | -$26.2K | – | 6079 |
|
|
2023
Q3 | $26.2K | Buy |
+1,274
| New | +$26.2K | ﹤0.01% | 5251 |
|
|
2023
Q1 | – | Sell |
-235
| Closed | -$31.7K | – | 6060 |
|
|
2022
Q4 | $31.7K | Buy |
+235
| New | +$31.7K | ﹤0.01% | 5421 |
|